Literature DB >> 15472918

Antiallergic activity of a disaccharide isolated from Sanguisorba officinalis.

Kwan Ha Park1, Dongsoo Koh, Kangjeon Kim, Jongmin Park, Yoongho Lim.   

Abstract

The antiallergic activity of the natural disaccharide, 5-O-alpha-D-(3-C-hydroxymethyl)lyxofuranosyl-beta-D-(2-C-hydroxymethyl)arabinofuranose was evaluated using both in vivo and in vitro experimental models. Intravenously administered compound inhibited the passive cutaneous anaphylaxis response in rats in a dose-dependent manner (ED(50) = 9.6 mg/kg). The compound inhibited histamine release evoked by both compound 48/80 and calcium ionophore A23187 in rat peritoneal mast cells indicating that mast cell stabilization is the major mechanism of action for its antiallergic activity. In passively sensitized isolated guinea-pig hearts, an in vitro anaphylaxis model in which histamine release plays a key role for functional deterioration, the compound markedly diminished both coronary flow reduction and histamine release on challenge to the antigen. These data demonstrate that this antiallergic natural disaccharide exerts its effect via inhibition of mast cell mediator release. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472918     DOI: 10.1002/ptr.1545

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

1.  Immunomodulatory Effects of ZYM-201 on LPS-stimulated B Cells.

Authors:  Ye Eun Lee; Soochan Kim; Woong-Jae Jung; Hyung Soo Lee; Mi-Yeon Kim
Journal:  Immune Netw       Date:  2014-10-22       Impact factor: 6.303

2.  Saponins from Sanguisorba officinalis Improve Hematopoiesis by Promoting Survival through FAK and Erk1/2 Activation and Modulating Cytokine Production in Bone Marrow.

Authors:  Xin Chen; Bogang Li; Yue Gao; Jianxin Ji; Zhongliu Wu; Shuang Chen
Journal:  Front Pharmacol       Date:  2017-03-16       Impact factor: 5.810

3.  Bioactivity-guided isolation and identification of anti-adipogenic compounds from Sanguisorba officinalis.

Authors:  Sun Hyuk Im; Zhiqiang Wang; Soon Sung Lim; Ok-Hwan Lee; Il-Jun Kang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

4.  Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model.

Authors:  Eun-Ji Lee; Ji Hye Kim; Tae In Kim; Yeon-Ji Kim; Malk Eun Pak; Chang Hyun Jeon; Yeo Jin Park; Wei Li; Young Soo Kim; Jang-Gi Choi; Hwan-Suck Chung
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.